Amino acid substitutions in core and NS5A regions of the HCV genome can predict virological decrease with pegylated interferon plus ribavirin therapy.
Kitamura S, Tsuge M, Hatakeyama T, Abe H, Imamura M, Mori N, Saneto H, Kawaoka T, Mitsui F, Hiraga N, Takaki S, Kawakami Y, Aikata H, Takahashi S, Ohishi W, Ochi H, Hayes CN, Chayama K.
Kitamura S, et al. Among authors: chayama k.
Antivir Ther. 2010;15(8):1087-97. doi: 10.3851/IMP1674.
Antivir Ther. 2010.
PMID: 21149915